ArticleKidney international reports2025

A Targeted-Release Formulation of Budesonide for the Treatment of IgA Nephropathy Patients With Severe Renal Impairment.

Yan Ouyang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.